Alentis Therapeutics
Jason R Dinges is the current Director at Alentis Therapeutics. Jason has also previously worked at IM Therapeutics, Apic Bio, Inc., Bacainn Therapeutics, CELLCENTRIC LIMITED, Cognito Therapeutics, Inc., Enyo Pharma, Kezar Life Sciences, Inc., Pinteon Therapeutics, Inc., Matatu, Inc., and Morningside Technology Advisory LLC. Jason R Dinges has also been an attorney at Foley & Lardner LLP from March 2007 to February 2011.
Jason Dinges has a J.D. from University of Iowa College of Law, a Ph.D. from Iowa State University, and a B.S. from Illinois Wesleyan University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Alentis Therapeutics
Alentis Therapeutics is developing breakthrough treatments for fibrotic disease and associated cancers.